Justin Walsh
Stock Analyst at JonesTrading
(4.57)
# 938
Out of 4,407 analysts
376
Total ratings
35.6%
Success rate
15.9%
Average return
Main Sectors:
Stocks Rated by Justin Walsh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BLRX BioLineRx | Reiterated: Buy | $12 | $3.37 | +256.08% | 10 | Jun 2, 2026 | |
| PRAX Praxis Precision Medicines | Reiterated: Buy | $441 | $266.58 | +65.43% | 11 | Jun 2, 2026 | |
| VNRX VolitionRx | Reiterated: Buy | $60 → $24 | $1.38 | +1,639.13% | 5 | May 18, 2026 | |
| SER Serina Therapeutics | Reiterated: Buy | $11 | $1.84 | +497.83% | 8 | May 18, 2026 | |
| CLNN Clene | Reiterated: Buy | $30 | $5.84 | +413.70% | 14 | May 15, 2026 | |
| RNXT RenovoRx | Reiterated: Buy | $8 | $0.8438 | +848.09% | 4 | May 15, 2026 | |
| ANRO Alto Neuroscience | Reiterated: Buy | $44 | $21.47 | +104.94% | 17 | May 15, 2026 | |
| CATX Perspective Therapeutics | Reiterated: Buy | $18 | $2.95 | +510.17% | 34 | May 14, 2026 | |
| NMTC NeuroOne Medical Technologies | Reiterated: Buy | $8 | $3.24 | +146.91% | 3 | May 13, 2026 | |
| TLSI TriSalus Life Sciences | Reiterated: Buy | $11 | $3.77 | +191.78% | 14 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $3.92 | +308.16% | 6 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $5.52 | +262.32% | 23 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $104.52 | - | 30 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $61 | $24.75 | +146.46% | 5 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $38.40 | +30.21% | 19 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $1.01 | +791.09% | 32 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $4.27 | +602.58% | 7 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2 | $0.371 | +439.08% | 11 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $14.36 | - | 27 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $59.59 | n/a | 7 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $5.01 | n/a | 16 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.40 | $0.02 | n/a | 6 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $2.78 | n/a | 6 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $4 | $1.73 | n/a | 9 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $0.43 | n/a | 12 | Jun 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $20 | $37.64 | n/a | 2 | May 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $0.447 | n/a | 15 | May 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $2.03 | n/a | 4 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 → $6 | $0.3998 | n/a | 3 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $31.59 | n/a | 2 | Apr 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $7 | $0.000001 | n/a | 2 | Jan 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.72 | n/a | 2 | Nov 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.45 | n/a | 3 | Nov 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $18.25 | n/a | 5 | Nov 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $40 | $0.2411 | n/a | 1 | Sep 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $4 | $1.15 | n/a | 1 | Feb 17, 2021 |
BioLineRx
Jun 2, 2026
Reiterated: Buy
Price Target: $12
Current: $3.37
Upside: +256.08%
Praxis Precision Medicines
Jun 2, 2026
Reiterated: Buy
Price Target: $441
Current: $266.58
Upside: +65.43%
VolitionRx
May 18, 2026
Reiterated: Buy
Price Target: $60 → $24
Current: $1.38
Upside: +1,639.13%
Serina Therapeutics
May 18, 2026
Reiterated: Buy
Price Target: $11
Current: $1.84
Upside: +497.83%
Clene
May 15, 2026
Reiterated: Buy
Price Target: $30
Current: $5.84
Upside: +413.70%
RenovoRx
May 15, 2026
Reiterated: Buy
Price Target: $8
Current: $0.8438
Upside: +848.09%
Alto Neuroscience
May 15, 2026
Reiterated: Buy
Price Target: $44
Current: $21.47
Upside: +104.94%
Perspective Therapeutics
May 14, 2026
Reiterated: Buy
Price Target: $18
Current: $2.95
Upside: +510.17%
NeuroOne Medical Technologies
May 13, 2026
Reiterated: Buy
Price Target: $8
Current: $3.24
Upside: +146.91%
TriSalus Life Sciences
May 13, 2026
Reiterated: Buy
Price Target: $11
Current: $3.77
Upside: +191.78%
May 13, 2026
Reiterated: Buy
Price Target: $16
Current: $3.92
Upside: +308.16%
May 12, 2026
Reiterated: Buy
Price Target: $20
Current: $5.52
Upside: +262.32%
May 8, 2026
Reiterated: Hold
Price Target: n/a
Current: $104.52
Upside: -
May 8, 2026
Reiterated: Buy
Price Target: $61
Current: $24.75
Upside: +146.46%
May 7, 2026
Reiterated: Buy
Price Target: $50
Current: $38.40
Upside: +30.21%
Apr 2, 2026
Reiterated: Buy
Price Target: $9
Current: $1.01
Upside: +791.09%
Mar 25, 2026
Reiterated: Buy
Price Target: $30
Current: $4.27
Upside: +602.58%
Mar 11, 2026
Reiterated: Buy
Price Target: $2
Current: $0.371
Upside: +439.08%
Jan 5, 2026
Rated: Hold
Price Target: n/a
Current: $14.36
Upside: -
May 14, 2025
Reiterated: Hold
Price Target: n/a
Current: $59.59
Upside: n/a
Mar 21, 2025
Rated: Hold
Price Target: n/a
Current: $5.01
Upside: n/a
Oct 30, 2024
Reiterated: Buy
Price Target: $0.40
Current: $0.02
Upside: n/a
Aug 8, 2024
Reiterated: Buy
Price Target: $20
Current: $2.78
Upside: n/a
Jun 4, 2024
Reiterated: Buy
Price Target: $8 → $4
Current: $1.73
Upside: n/a
Jun 6, 2022
Reiterated: Buy
Price Target: $10
Current: $0.43
Upside: n/a
May 19, 2022
Maintained: Buy
Price Target: $16 → $20
Current: $37.64
Upside: n/a
May 19, 2022
Reiterated: Buy
Price Target: $18
Current: $0.447
Upside: n/a
May 10, 2022
Reiterated: Buy
Price Target: $10
Current: $2.03
Upside: n/a
May 4, 2022
Maintained: Buy
Price Target: $7 → $6
Current: $0.3998
Upside: n/a
Apr 7, 2022
Maintained: Buy
Price Target: $10
Current: $31.59
Upside: n/a
Jan 11, 2022
Upgraded: Buy
Price Target: $7
Current: $0.000001
Upside: n/a
Nov 26, 2021
Rated: Hold
Price Target: n/a
Current: $4.72
Upside: n/a
Nov 26, 2021
Rated: Hold
Price Target: n/a
Current: $4.45
Upside: n/a
Nov 17, 2021
Reiterated: Buy
Price Target: $30
Current: $18.25
Upside: n/a
Sep 2, 2021
Initiated Coverage: Buy
Price Target: $40
Current: $0.2411
Upside: n/a
Feb 17, 2021
Initiated Coverage: Buy
Price Target: $4
Current: $1.15
Upside: n/a